Complement Therapeutics enrols first patient in non-interventional i-GAIN study of people diagnosed with geographic atrophy

Complement Therapeutics Ltd (CTx), a preclinical stage biotechnology company, today announced enrolment of the first patient in a natural history study of people who have been diagnosed with geographic atrophy (GA).

ACROBiosystems announces the start of its recombinant antibody services

ACROBiosystems has now officially begun its recombinant antibody services which includes comprehensive services encompassing gene construction, expression, purification and quality inspection.

Coulter Partners places three Board Directors at Our Future Health Trading Ltd

Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health, and Tech, recently partnered with Our Future Health Trading Ltd, and is pleased to announce the placements of Cristina Ortega Duran, Andy Richards and Simon Sturge as Board Directors.

Imperial startup Biocentis to develop genetic tech to control harmful insects

Biocentis has received investment to use CRISPR-based gene-editing to control insect populations that harm health, food security and biodiversity. The Imperial College London startup was founded in 2022 by Imperial researchers in partnership with technology-focused investment group Neurone to create a more effective and sustainable alternative to pesticides.

Biomatics launches specialist Bioinformatics Services

For organisations undertaking genomics work, various challenges restrict them in achieving success. The bioinformatics industry is continuing to grow but major challenges include finding skilled personnel with bioinformatics knowledge and the ability to rapidly extract data from biological data.

Legal and General and Bruntwood JV - Bruntwood SciTech, post record profits

Bruntwood SciTech post pre-tax profit of £114 million – the most since its formation in 2018; Net asset value increases 36% to £321.1 million and total assets under management hits £858.44 million; £91 million of capital investment including first move into Scotland and significant progress on key developments. Completions of Enterprise Wharf and No.1 Birmingham Health Innovation Campus and construction kick off at Glasgow’s Met Tower and Citylabs 4.0 to come in 2023

CEO Update | 6 February 2023

Thank you for your ongoing support for our SME R&D tax relief campaign highlighting the negative impact of the relief rate changes announced in the Autumn Statement for biotech. Thanks to our combined efforts, the Chancellor has said he sees 'merit to the case for further support' for 'R&D intensive businesses'. This is great news, but the devil will be in the detail, so we need your help. Please complete our survey.

World Cancer Day: Meet Infinitopes

For World Cancer Day this weekend, we spoke with Dr Jonathan Kwok, CEO of Infinitopes, a Cancer Research UK (CRUK)-led precision immunology spinout from Oxford University. Dr Kwok describes the challenges of creating novel targeted treatments for cancer, overcoming difficult financial markets, and the importance of working with a passionate team. Infinitopes is also recruiting…

National Apprenticeship Week: Lara's journey to gaining 'Skills for Life'

It's National Apprenticeship Week! This week (6-12 February) we're celebrating everything apprenticeships, with the 2023 #NAW theme being 'Skills for Life'. We spoke to Lara Devenish, Quality Control Associate Scientist at Autolus. Following her sixth-form studies, she joined Autolus as an apprentice where she obtained her foundation degree and bachelor's degree in bioscience. Please continue reading to learn about her experience as an apprentice. 

Firefinch Software announces partnership with i4 Product Design

Firefinch Software and i4 Product Design (i4PD) have announced that they have entered into a strategic partnership that will bring together the market leading software expertise of Firefinch Software with the hardware product design and development experience of i4PD, creating a one stop shop for start-ups and new businesses looking to bring their ideas quickly to market.